SCHEMBL21885547

SCHEMBL21885547

Cc1ccc(S(=O)(=O)N(C)C(Cc2ccccn2)C(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 1/20 0.52
KMT2A Q03164 5/20 0.48
MEN1 O00255 1/20 0.48
PTPRA P18433 1/20 0.47
GAA P10253 1/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 1/20 0.46
KDM4E B2RXH2 3/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44
ADRB2 P07550 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PTGS2 P35354 1/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
AGER Q15109 1/20 0.43
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16058321 1.00 ADAMTS5 (0.52) ADAMTS5KMT2AMEN1PTPRAGAA
Bromide SCHEMBL29831731 0.99 ADAMTS5 (0.51) ADAMTS5KMT2AMEN1PTPRAGAA
SCHEMBL5573300 0.82 ADAMTS5 (0.73) ADAMTS5KMT2AGAAPOLBMAPT
SCHEMBL5573297 0.82 ADAMTS5 (0.73) ADAMTS5KMT2AGAAPOLBMAPT
SCHEMBL28583121 0.80 MEN1 (0.48) ADAMTS5KMT2AMEN1PTPRAGAA
SCHEMBL5572738 0.77 GAA (0.59) KMT2AMEN1GAAALDH1A1CYP3A4
SCHEMBL17481680 0.76 AGER (0.54) ADAMTS5KMT2AMEN1ALDH1A1MAPT
SCHEMBL5573156 0.76 AGER (0.54) ADAMTS5KMT2AALDH1A1MAPTKEAP1
SCHEMBL21885546 0.75 TDP1 (0.58) ADAMTS5KMT2AALDH1A1POLBMAPT
SCHEMBL16058523 0.75 TDP1 (0.58) ADAMTS5KMT2AALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10639308-B2 sGC stimulators CYCLERION THERAPEUTICS, INC. (US) 2020-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10639308-B2 sGC stimulators PTGIS, CGAS, GUCY1A1 ADAMTS5 4259/4885KMT2A 4250/4885MEN1 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.